Originally published In Press as doi:10.1074/jbc.M001569200 on March 29, 2000
J. Biol. Chem., Vol. 275, Issue 29, 22363-22372, July 21, 2000
The Sarco/Endoplasmic Reticulum Calcium-ATPase 2b Is an
Endoplasmic Reticulum Stress-inducible Protein*
Casper
Caspersen
§¶,
Peter Sten
Pedersen
, and
Marek
Treiman
§
From the
Department of Medical Physiology and the
§ Biotechnology Center for Cellular Communication, The Panum
Institute, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark
Received for publication, February 25, 2000, and in revised form, March 10, 2000
 |
ABSTRACT |
The sarco/endoplasmic reticulum calcium-ATPase
(SERCA) translocates Ca2+ from the cytosol to the
lumen of the endoplasmic reticulum. This Ca2+ storage is
important for cellular processes such as calcium signaling and
endoplasmic reticulum (ER)-associated posttranslational protein modifications. We investigated the expression of the SERCA2 and SERCA3
isozymes in PC12 cells exposed to agents interfering with different
aspects of the posttranslational protein processing within the ER,
thereby activating the ER stress-induced unfolded protein response
(UPR). All agents increased the SERCA2b mRNA level 3-4-fold, in
parallel with increasing mRNA levels for the ER stress marker
proteins BiP/GRP78 and CHOP/GADD153. In contrast, SERCA3 mRNA
levels did not change. SERCA2b mRNA stability was not changed,
indicating that the mechanism of its up-regulation was transcriptional,
in accordance with the presence of ER stress response elements in the
promoter region of the SERCA2 gene. SERCA2b was also increased at the
protein level upon ER stress treatments. Induction of ER stress by
tunicamycin, dithiothreitol, or L-azetidine 2-carboxylic
acid did not result in depletion of ER calcium, showing that such
depletion was not necessary for up-regulation of SERCA2b expression or
UPR activation in general. We conclude that the SERCA2b expression can
be controlled by the UPR pathway independently of ER Ca2+ depletion.
 |
INTRODUCTION |
The Ca2+ storage of endoplasmic reticulum
(ER)1 is crucial for a
variety of Ca2+-dependent processes, such as
Ca2+-mediated cytosolic signaling in response to external
stimuli (1), cell growth, and proliferation (2, 3), as well as synthesis, posttranslational processing, folding and export of proteins
synthesized on ER-associated ribosomes (4-6). The maturation of the
newly translocated polypeptide chains within the ER lumen is
accomplished by transient interactions with ER chaperones (such as
calreticulin, calnexin, BiP/GRP78, GRP94, and others) (7, 8). The
requirement for Ca2+ as a co-factor for proper ER protein
processing and maturation presumably results from the Ca2+
binding capacities and Ca2+ -dependent
interactions of the chaperones in the ER lumen (9).
The resting intra-ER free Ca2+ concentration is 3-4 orders
of magnitude higher than the cytosolic Ca2+ concentration
([Ca2+]i) (10). This gradient is generated by the
sarco/endoplasmic reticulum Ca2+-ATPases (SERCAs), encoded
by three homologous genes (SERCA1, SERCA2, and SERCA3) (11).
Transcripts from all three genes undergo alternative splicing in a
developmentally and tissue-specific manner, giving rise to a number of
isozymes differing in their C-terminal regions. The splicing of the
primary transcripts from SERCA1 and SERCA2 genes produces SERCA1a-b
(12) and SERCA2a-b isozymes (13, 14). SERCA1a-b and SERCA2a expression
is restricted to skeletal and cardiac muscles, whereas the SERCA2b
isoform is ubiquitously expressed in all nonmuscle tissues (15).
Recently, SERCA3 transcripts were found to be spliced too, resulting in three isozymes in mice and humans (SERCA3a, SERCA3b, and SERCA3c) (16)
and two isozymes in rats (SERCA3a and SERCA3b/c) (11, 17). SERCA3 is
expressed in a number of nonmuscle tissues at variable levels, always
coexpressed with SERCA2b (15, 18, 19). At present, the full
physiological significance of this heterogeneity among the SERCA
isozymes remains unclear.
When unfolded proteins accumulate in the ER, a conserved eukaryotic
stress response pathway known as unfolded protein response (UPR) is
activated (8, 20, 21). This response amplifies the protein folding
capacity in the ER through an enhanced expression of the ER-resident
chaperones (such as BiP), thus counteracting congestion of misfolded
protein intermediates and promoting cell survival (22, 23). Ire1p,
residing in the ER membrane and displaying both serine/threonine kinase
and endonuclease activities, appears to function as the sensor of the
accumulation of unfolded proteins and to activate the signal that
enhances the transcription of chaperone genes in yeast (24) as well as
mammals (25, 26). Recently, stress inducibility of the chaperone genes
in higher eukaryotes was shown to require the presence of a 19-base
pair long regulatory elements termed ER stress response elements
(ERSEs) in their promoters (27, 28). In addition to chaperone
up-regulation, several other signals emerge from the stressed ER,
including induction of a growth arrest/cell death-promoting
transcription factor C/EBP homology protein (CHOP, also known as growth
arrest and DNA damage protein 153) (29), and in a number of cases,
protein synthesis is transiently down-regulated because of
phosphorylation of eukaryotic initiation factor 2
by the dedicated
kinases PKR-like ER kinase (30) and possibly PKR (31).
Here we present results showing a strong correlation between induction
of the UPR pathway and an elevated expression of SERCA2b, but not
SERCA3, at the mRNA and protein levels. Depletion of ER calcium was
not a necessary condition for UPR activation nor for the up-regulation
of SERCA2b. Together with the presence of putative functional ERSE
elements in the promoter region of SERCA2 gene, these results provide
evidence for a new aspect of SERCA2b function, manifested by its
ability to act as a member of the ER stress protein family.
 |
EXPERIMENTAL PROCEDURES |
Materials and Reagents--
PC12 cells were provided by Dr. S. Gammeltoft (Copenhagen County Glostrup Hospital). RINm5F cells were
provided by Dr. K. Josefsen (Bartholin Institute, Copenhagen).
Thapsigargin was a gift from Dr. S. B. Christensen (Royal Danish
School of Pharmacy). Immune sera against SERCA2b and SERCA3 were
generously provided by Dr. Frank Wuytack (Leuven, Belgium).
L-[4,5-3H]-leucine,
methyl-[3H]thymidine, [
-32P]dCTP,
[
-32P]ATP, and autoradiography films were from
Amersham Pharmacia Biotech. Fetal bovine serum, horse serum, and cell
culture media were from Life Technologies, Inc.
Cell Culture--
PC12 cells were cultured in Dulbecco's
modified Eagle's medium with 25 mM Hepes, 4500 mg/liter
glucose supplemented with 6% (v/v) heat-inactivated fetal calf serum,
6% (v/v) heat-inactivated horse serum, 18 µg streptomycin/ml, and 18 units penicillin/ml. RINm5F cells were cultured in RPMI 1640 medium, 25 mM Hepes supplemented with 10% heat-inactivated fetal calf
serum, 18 µg streptomycin/ml and 18 units penicillin/ml. Cells were
passaged once every week.
Use of Stress Agents--
Compounds to be added to the cells in
culture medium were prepared as stock solutions concentrated 1000-fold
in Me2SO (thapsigargin, A23187, tunicamycin, brefeldin A,
actinomycin D), 100-fold in water (L-azetidine 2-carboxylic
acid, EGTA), or 1000-fold in water (cycloheximide, DTT). The EGTA stock
was adjusted to pH 9.16 to counter the pH fall upon its addition.
Equivalent volumes of Me2SO or water were added to control
cell batches. Final agent concentrations are given in the figure legends.
DNA Probes--
RNA isolated from rat cerebellum or PC12 cells
was used for cDNA cloning. cDNA fragments were amplified by
reverse transcription-polymerase chain reaction using Ready To Go,
Specific, or Poly-dT Primed First Strand cDNA Synthesis kit from
Amersham Pharmacia Biotech. For the polymerase chain reaction, the
following primers were used (GenBankTM accession numbers in
parentheses): GAPDH (X02231), 5'-ATGACTCTACCCACGGCAAG-3', 5'-CCACAGTCTTCTGAGTGGCA-3'; SERCA3 (M30501),
5'-GGCCCTCAAGTATCTGTCCA-3', 5'-GAAGCTGAGCCAAGTGGAAG-3'; SERCA2b
(J04022), 5'-TATTGGCTGGTGAAGGAGGT-3', 5'-GGTGACAGAGGCTGAGGGT-3'; BiP
(M14050), 5'-AGCCCACCGTAACAATCAAG-3', 5'-TCCAGCCATTCGATCTTTTC-3'; CHOP
(U30186) 5'-AGCTGAGTCTCTGCCTTTCG-3', 5'-TGTGGTCTCTACCTCCCTGG-3'; and
HSP70 (X77208) 5'-TGCTGATCCAGGTGTACGAG-3', 5'-GCTGATCTTGCCCTTGAGAC-3'.
The amplified cDNAs were cloned into the pMOSblue T-vector
(Amersham Pharmacia Biotech) and sequenced by dideoxy sequencing.
Polymerase chain reaction-amplified cDNA inserts were gel purified
and used as probes. Probes were labeled using Ready To Go DNA labeling
beads, purified using Probe Quant reagents kits (both from Amersham
Pharmacia Biotech), and denatured in 0.1 M NaOH at 37 °C
for 10 min prior to addition to hybridization solution. GAPDH probes
with a 10-fold reduced specific activity were used when cohybridized
with the SERCA3 and SERCA2b probes.
Northern Blots and Hybridization--
PC12 or RINm5F cells were
seeded on rat tail collagen-coated 100-mm dishes (3.5 µg
collagen/cm2). Total RNA was isolated by a modified
acid/phenol procedure (32), where the RNA was solubilized and stored in
formamide after drying the final RNA pellet. RNA samples were run on a
formaldehyde-agarose gel, transferred to nylon membranes (Hybond N,
Amersham Pharmacia Biotech), and fixed by UV light according to
standard procedures (33). Proper transfer of RNA was assured by
staining the nylon membrane in 0.03% (w/v) methylene blue in 0.3 M NaCH3 COO (pH 5.3). RNA size standards (Life
Technologies, Inc.) (0.24, 1.35, 2.37, 4.4, 7.46, and 9.49 kb) were
used to determine mRNA size. Each Northern blot was washed 15 min
at 65 °C in the hybridization solution (0.25 M
Na2HPO4, pH 7.1, 1 mM EDTA, 7%
(w/v) SDS) and probed overnight in the hybridization solution at
65 °C with [
-32P]dCTP-labeled probe. The blot was
then washed by adding a 65 °C hot wash solution (50 mM
Na2HPO4, pH 7.1, 1 mM EDTA, 2.5%
SDS), and the wash was continued at room temperature with four changes, each of 10-min duration. The blot was autoradiographed on the Hyperfilm
MP (Amersham Pharmacia Biotech) for 5 h to 2 days. Some of the
Northern blots were stripped in boiling 0.1% (w/v) SDS before
reprobing. Quantitation was obtained by digital scanning of the films
using the NIH Scion Image program.
Immunostaining of Western Blots--
Total cellular protein
lysates were prepared in 20 mM Tes (pH 7.4), 4% SDS, 1%
DTT, 1 mM EDTA, and 10% glycerol. 15 or 50 µg
protein/lane was run on a 7% SDS-PAGE (34) and transferred to
nitrocellulose membranes. Nitrocellulose membranes were blocked at
4 °C for 5 h. Blocking before the SERCA2b detection was in 5%
(w/v) nonfat dry milk (milk), 0.1% Tween 20 in PBS (10 mM
Na2HPO4, pH 7.4, 150 mM NaCl).
Blocking before the SERCA3 detection was in 45% (w/v) fetal bovine
serum, 10% milk, and 1% Nonidet P-40, 1% Triton X-100, 1% Tween 20 (all v/v) in TBS (10 mM Tris-HCl, pH 7.5, 150 mM NaCl). SERCA2b antiserum (35) was diluted 1:12,000 in
5% milk, 0.1% Tween 20, 1% Nonidet P-40 in TBS. SERCA3-antiserum (N89) (36) was diluted 1:9000 in 15% fetal bovine serum, 10% milk,
1% Nonidet P-40, 1% Triton X-100, 1% Tween 20 in TBS. The blots were
incubated overnight at 4 °C with agitation. The blots were washed
four times for 5 min in 0.1% Tween 20, 0.1% Triton X-100, 0.2% (w/v)
SDS in PBS (wash buffer) at room temperature. The secondary anti-rabbit
antibody coupled to horseradish peroxidase (Bio-Rad) was diluted
1:17,000 (for SERCA2b staining) or 1:10,000 (for SERCA3 staining) in
0.1% Tween 20, 5% milk in PBS, incubated with agitation 2 h at
room temperature, and washed in the wash buffer. Western blots were
stained by a chemiluminescence method using a staining solution
consisting of luminol (3.9 mM), hydrogen peroxide (7.8 mM), p-iodophenol (2.5 mM) (all in
100 mM Tris, pH 8.5) and SSC (2.5×). ECL-Hyperfilm was
exposed for 15-30 s. Films were quantitated as described above.
DNA and Protein Synthesis Rates, Cell Viability, and SERCA
Immunostaining--
These procedures were each carried out on a
portion of the same pool of cells. 3 × 106 PC12 cells
were treated for 8 h with the indicated stressor, resuspended in 5 ml of the medium in which they had been cultured, and finally divided
into four tubes.
Protein Synthesis Rate--
2 ml of cells were centrifuged at
100 × g for 10 min at room temperature. The
supernatant was discarded, and the remaining cells were centrifuged in
leucine-free Dulbecco's modified Eagle's medium and resuspended in 2 ml of leucine-free Dulbecco's modified Eagle's medium with the same
stress agent as used prior to harvesting, and 2.5 µl (18 pmol) of
L-[4,5-3H]-leucine. Cells were labeled for 7 min at 37 °C. Labeling was stopped by addition of 1 ml of 0.1 M NaOH, after which the tube was cooled on ice.
Macromolecules were precipitated by 5 ml of ice-cold 10%
trichloroacetic acid, and the pellet was washed three times with 5 ml
of ice-cold 5% trichloroacetic acid. Finally the pellet was
solubilized in 0.25 M NaOH and counted by liquid scintillation.
DNA Synthesis Rate--
1 ml of cells were labeled with 2 µl
(80 pmol) of methyl-[3H]thymidine. The labeling reaction
was stopped after 15 min at 37 °C by 1 ml of 0.1 M NaOH,
after which the tube was transferred to ice. Macromolecules were
precipitated and washed, and the radioactivity was counted as described above.
Cell Viability--
A 150-µl aliquot was taken out for cell
counting and viability test. Cells were mixed 1:1 with 0.4% (w/v)
trypan blue in PBS. After 2 min at room temperature, dead (blue) and
live (not stained) cells were counted in a hemocytometer.
Cytosolic Calcium Measurements--
PC12 cells cultured on
polylysine-coated (100 µg/ml) glass coverslips were loaded for 30 min
at 37 °C with 5 µM fura-2 acetoxymethyl ester and
0.04% pluronic F-127 (Molecular Probes) in EM solution (145 mM NaCl, 5 mM KCl, 20 mM Hepes, 3 mM CaCl2, 1 mM MgCl2,
10 mM glucose, and 100 µM
sulfinpyrazon). The coverslip was then transferred to a
solution consisting of 75% (v/v) EM solution with 25% (v/v) culture
medium for additional 30 min at 37 °C and 5% CO2. The
coverslip was placed in a 37 °C thermostated chamber (PH1 and
TC344A, Warner Instruments, Hamden, CT) with 75% (v/v) EM solution and
25% (v/v) culture medium. For measurements in the absence of
extracellular Ca2+, cells were washed three times in
Ca2+-free extracellular solution. Ca2+-free
extracellular solution was EM solution with no Ca2+ added
(nominally Ca2+-free) or nominally Ca2+-free EM
solution supplemented with 25 µM EGTA, as indicated in the figure legends. Dual excitation single emission fluorescence ratio
imaging was performed using a system composed of the following: light
from a high intensity source (XBO 75 W, OSRAM, Berlin, Germany) was
passed via a monochromator (FL3095, J & M, Analytische Mess, Frankfurt, Germany), programmed to pass light of 340 and 380 nm. This light was transmitted into an inverted microscope (Nikon Diaphot
300), containing a 405-nm dichroic mirror and 510-nm long pass emission
filter. Cells were imaged using a 40× lens (Zeiss Fluar, 40/1.30 oil).
Emitted light was collected by a high resolution image intensifier
coupled to a video camera (GenIIsys, CCD-72EX, DAGE-MTI, Michigan City,
IN). The signal output from the camera was connected to a digital
image-processing board (Matrox, MVP-AT) controlled by IMAGE-1/FL
software (Universal Imaging, West Chester, PA). The digitized signal
output from cells excited at each wavelength with an interval of 5 s was processed on-line (four frame average) to yield a ratio image
map. [Ca2+]i values were collected from within
the camera field as averaged signals from a circular measurement window
placed over each cell. The ratio values were converted to intracellular Ca2+ concentration ([Ca2+]i) by means
of the formula of Grynkiewicz et al. (37).
Measurement of the SERCA Phosphorylated
Intermediate--
Following harvesting and centrifugation, cells were
washed once in PBS and resuspended in 20 mM Tes (pH 7.0)
and sucrose 300 mM (HB). Cells were broken by means of a
cell cracker from the European Molecular Biology Laboratory workshop
(38), employing the clearance of 12 µm and 10 passages. The
homogenates were centrifuged for 10 min at 10,000 × g,
followed by centrifugation of the supernatants for 60 min at
100,000 × g. The microsomal pellets were resuspended in HB and stored at
80 °C. ATPase phosphorylation was carried out
as described earlier ("standard assay") (39).
 |
RESULTS |
SERCA2b mRNA Is Induced by ER Stress--
We have challenged
PC12 cells with different agents sharing the ability to induce the
mammalian UPR and measured the level of SERCA2b and SERCA3 mRNAs on
Northern blots. The SERCA2b probe hybridized with the 4.5-, 6-, and
8-kb alternative splice variants of SERCA2b mRNA, differing in
their 3'-untranslated region (11, 13). The SERCA2a mRNA was not
expressed in PC12 cells (not shown). Fig.
1A shows that after a 6-h
exposure, the agents known to perturb and deplete intra-ER
Ca2+ (thapsigargin, A23187, or EGTA) all induced an
increase in the SERCA2b mRNA level relative to control cells
exposed to the appropriate vehicle (Me2SO or water).
Thapsigargin is an inhibitor of SERCA pumps (40), A23187 is an
ionophore known to collapse divalent cation gradients (41), whereas
EGTA treatment chelates extracellular Ca2+, thereby
promoting Ca2+ efflux from the cell and ER. The level of
SERCA3 mRNA was not changed by these agents (Fig. 1B).
In addition, tunicamycin, DTT, L-azetidine-2-carboxylic
acid (Azc), and brefeldin A (BFA) also induced an increase in the
SERCA2b, but not the SERCA3, mRNA level (Fig. 1, A and
B). Tunicamycin is an inhibitor of N-linked
glycosylation (42). DTT perturbs the unique oxidative milieu of the ER
lumen, thereby inhibiting the disulphide bond-dependent
protein folding (43). Azc is a proline analog that is incorporated into
proteins and causes their misfolding (44). BFA is an inhibitor of the transport from ER to Golgi, leading to an absorption of the Golgi apparatus into the ER (45). The treatments did not cause any major
changes in the yield of total isolated RNA, except for Azc, which
decreased the RNA yield to 50-60% of controls. Fig. 1C
shows the quantitation of the relative levels of mRNA for SERCA2b
and SERCA3, as normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Regulation of SERCA2b mRNA level by ER
stressors. Total RNA was isolated from PC12 cells after 6 h
of exposure to the indicated agents: Tg (200 nM), A23187 (5 µM), EGTA (2.5 mM), Tun (10 µg/ml), DTT
(0.8 mM), BFA (5 µg/ml), and Azc (5 mM). 10 µg of RNA was loaded on each gel lane. Except for C,
autoradiograms are shown of Northern blots hybridized with the probes
for the indicated mRNA species (size in kb). In this and other
figures, GAPDH mRNA is indicated at 1.4 kb on each autoradiogram.
The amount of GAPDH mRNA was unaffected by various treatments and
was used to control for equal loading of gel lanes. For each condition,
n indicates number of experiments represented by the figure.
A, SERCA2b mRNA (alternative mRNA splice variants
are indicated at 8, 6, and 4.5 kb). For EGTA, Tg, and A23187,
n = 6. For Tun and DTT, n = 5. For BFA
and Azc, n = 3. B, SERCA3 mRNA (4.8 kb).
n values are as in A. C, quantitation
of SERCA2b and SERCA3 mRNA levels in response to ER stressors, as
shown in A and B of this figure. Optic density
values of SERCA2b and SERCA3 mRNA autoradiographic bands were
normalized to those for GAPDH. Fold increase refers to the ratios
between values representing each treatment and the control to which
appropriate vehicle was added (H2O or Me2SO).
Bars represent standard deviations. D, BiP
mRNA (2.7 kb), n = 3. E, CHOP
mRNA (1.1 kb), n = 3. Statistical significance of
differences relative to control for SERCA2b mRNA, p < 0.02 (*). Student's t test was used. DMSO,
dimethyl sulfoxide.
|
|
As a positive control of the UPR induction, we monitored BiP and CHOP
mRNA levels in PC12 cells exposed to stressors. Panels D
and E in Fig. 1 show Northern blots of the same total RNA as analyzed in panels A and B, hybridized to BiP and
CHOP probes. The pattern of BiP induction resembled the induction of
SERCA2b mRNA, except for the induction magnitude (up to 10-fold,
quantitation not shown) compared with 3-4-fold of SERCA2b (Fig.
1C). CHOP mRNA was not detectable in control cells but
was induced by all the stressors, with the level of CHOP mRNA
induction highly dependent on the particular stressor. CHOP induction
by DTT at 6 h was very weak and is better appreciated at 1 or
2 h of DTT treatment (Fig. 2D).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 2.
Time course of SERCA2b mRNA
induction. Autoradiograms of Northern blots hybridized with the
probes for the indicated mRNA species are shown. PC12 cells were
treated with DTT (1 mM) or EGTA (2.5 mM) for 1, 2, 4, or 8 h, as indicated, and total RNA was isolated.
H2O denotes addition of an equivalent volume of water to
control cells. 10 µg of RNA was loaded on each gel lane. The mRNA
species and the number of experiments represented were as follows.
A, SERCA2b, n = 4. B, SERCA3,
n = 3. C, BiP, n = 3. D, CHOP, n = 4.
|
|
SERCA2b and BiP mRNA Induction Follows Similar
Kinetics--
To further characterize the SERCA2b mRNA induction
we compared the time course with that of BiP and CHOP. Fig.
2A shows an autoradiogram of a SERCA2b-probed Northern blot
with total RNA isolated from cells treated for 1, 2, 4, or 8 h
with EGTA or DTT. Fig. 2C shows a corresponding Northern
blot hybridized with a BiP probe. Both BiP and SERCA2b were induced in
1-2 h, consistent with the described pattern of BiP induction (46).
For both SERCA2b and BiP maximum was reached in about 2 h with DTT
and 4 h with EGTA. The same overall kinetics was found for
tunicamycin and A23187 (not shown). Longer stress periods (up to
24 h) did not increase SERCA2b mRNA level further. Fig.
2B shows an autoradiogram of SERCA3-probed Northern blot,
demonstrating that SERCA3 mRNA level did not change in response to
DTT or EGTA after 1, 2, 4, or 8 h.
The time course of the CHOP mRNA induction (Fig. 2D)
appeared faster than for the BiP or SERCA2b mRNA. CHOP mRNA
level reached a maximum in the presence of DTT within 1 h and was
decreasing thereafter to become undetectable after 8 h. However,
addition of fresh DTT after 4 h led to an increase in the CHOP
mRNA after 8 h to the same level as at 4 h (not shown),
indicating that the decreasing CHOP mRNA response to DTT, at least
in part, was the result of the inactivation of DTT.
The SERCA2b Induction Is Reversible and Reinducible--
To test
whether the increase in SERCA2b mRNA levels was reversible and
reinducible, cells were treated with EGTA for 4 h, after which the
medium was changed to control medium for 20 h, to be followed
again by EGTA treatment for 4 h. As shown in Fig. 3, SERCA2b, CHOP, and BiP responses were
reversible and could be reinduced after 20 h of reconstitution in
control medium. Both BiP and SERCA2b mRNA levels remained elevated
for 2 and 4 h after the withdrawal of the stressor (Fig. 3, time
points 6-8 and 30-32 h), after which they returned to the basal level
(time point 24 h).

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 3.
Reversible and repeated induction of SERCA2b,
BiP and CHOP mRNAs. Autoradiograms of Northern blots
hybridized with SERCA2b, BiP and GAPDH, and CHOP and GAPDH probes. PC12
cells were exposed to medium with 2.5 mM EGTA for 4 h,
followed by a control medium for 20 h. The cells were then
re-exposed to the 2.5 mM EGTA-containing medium for 4 h, followed again by 4 h of control medium.Total RNA was isolated
at the indicated times, and 10 µg/gel lane was analyzed.
Representative of three independent experiments.
|
|
In contrast to BiP and SERCA2b, CHOP mRNA level responded much more
promptly to the application and withdrawal of EGTA (Fig. 3). Notably,
for all three mRNA types, the second response to the stressor
appeared less pronounced than the first one.
The SERCA2b mRNA Increase Is Dependent on Protein
Synthesis--
A characteristic feature of the UPR is the requirement
of protein synthesis for the transcriptional induction of BiP mRNA (46). Fig. 4A shows that
neither tunicamycin nor A23187 were able to induce the SERCA2b mRNA
in the presence of cycloheximide, demonstrating that protein synthesis
was necessary for stress-mediated SERCA2b mRNA induction.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 4.
Stress-mediated SERCA2b mRNA induction is
dependent on protein synthesis and transcription, and SERCA2b mRNA
is not stabilized in stressed cells. Autoradiograms of Northern
blots probed for SERCA2b and GAPDH mRNAs are shown. Total RNA was
isolated, and 10 µg/lane was analyzed on agarose gels. A,
PC12 cells were treated for 4 h with 10 µg/ml Tun, 5 µM A23187, or an equivalent volume of the vehicle
(dimethyl sulfoxide), in the presence (+) or absence ( ) of 20 µM cycloheximide (representative of two experiments).
B, PC12 cells were treated for 4 h with 10 µg/ml Tun,
5 µM A23187, or an equivalent volume of the vehicle
(dimethyl sulfoxide) in the presence (+) or absence ( ) of 2 µM actinomycin D (representative of two experiments).
C, PC12 cells were preincubated with control medium or 10 µg/ml tunicamycin-containing medium for 4 h. The medium was then
replaced with one of the same composition (indicated by DMSO
or Tun), except for the addition of 2 µM
actinomycin D, and the incubation was continued for additional 3 or
6 h (representative of three independent experiments).
DMSO, dimethyl sulfoxide.
|
|
The Stress-induced Increase in SERCA2b mRNA Level Is Dependent
on Transcription, and SERCA2b mRNA Is Not Stabilized under
Conditions of ER Stress--
Fig. 4B shows that actinomycin
D, an inhibitor of transcription (47), could prevent the A23187 or
tunicamycin-mediated elevation of SERCA2b mRNA. To test whether
SERCA2b mRNA is stabilized under the conditions of ER stress, cells
were incubated in the presence of tunicamycin or the vehicle for 4 h, following which (Fig. 4C, time 0) each medium
was replaced with a similar one except for the addition of actinomycin
D. Fig. 4C shows that after 6 h in the presence of
actinomycin D, the SERCA2b mRNA decreased in both control and
tunicamycin-treated cells. Quantitation showed a decline to about 40%
of the level before addition of actinomycin D. Without the addition of
actinomycin D the SERCA2b mRNA was increasing throughout the
tunicamycin treatment (not shown). Total RNA yield decreased after
6 h of actinomycin D treatment to 60-80% of control in both the
vehicle and the tunicamycin-treated cells. Thus, SERCA2b mRNA was
not stabilized in response to tunicamycin-induced ER stress.
Up-regulation of SERCA2b, but Not SERCA3, mRNA in RINm5F
Insulinoma Cells in Response to ER Stress--
To test whether the
differential effect of ER stress on the 2 SERCA isoforms was present in
other cell types, we tested RINm5F insulinoma cells (derived from rat
pancreatic 74 cells) known to have a high expression level of SERCA3
(48). Fig. 5 shows that the various
stress-inducing agents caused an elevation of SERCA2b, but not of
SERCA3, mRNA in RINm5F cells, suggesting that the selective SERCA2b
mRNA induction under ER stress conditions is a general response
displayed by cells of different lineages. An elevation of SERCA2b
mRNA in response to ER stressors was also found in EL4 lymphoma
cells (not shown).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 5.
SERCA2b mRNA induction in RINm5F cells
with ER stressors. Autoradiograms of Northern blots analyzed for
SERCA2b (A), SERCA3 (B), and GAPDH (A
and B) are shown. RINm5F cells were exposed for 5 h to
the stress agents as follows: Tg (200 nM), A23187 (5 µM), EGTA (2.5 mM), Tun (10 µg/ml), DTT
(0.8 mM), BFA (5 µg/ml), Azc (5 mM), and
total RNA was isolated. 7 µg of RNA was loaded/lane (representative
of three (A) or two (B) experiments).
|
|
SERCA2b Expression Is Down-regulated by Heat Shock--
A response
to unfolded/malfolded proteins in the cytosolic compartment is another
major stress-induced pathway in the cell. This pathway is highly
activated upon heat exposure and is known as the heat shock response
(49), whereas the UPR is normally not induced by heat shock. We tested
whether SERCA2b mRNA level changed upon activation of the heat
shock response. PC12 cells were incubated for 4 h at 42 °C, and
RNA was isolated. Fig. 6 shows that the
SERCA2b mRNA was down-regulated upon heat shock, whereas mRNA
for the heat shock protein 70 (HSP70), a classical heat
stress-responsive chaperone, was highly induced. On the other hand,
HSP70 was not induced upon treatment of the cells with A23187 and
tunicamycin (not shown), showing a clear dissociation of the ER stress
and heat shock-activated response pathways.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 6.
SERCA2b mRNA is down-regulated by heat
shock. Autoradiogram of a Northern blot was hybridized first with
SERCA2b and GAPDH probes and then rehybridized with HSP70 probe. PC12
cells were incubated for 4 h at 37 or 42 °C, as indicated. 10 µg/lane of total RNA was analyzed (representative of two independent
experiments).
|
|
Stressed Cells Show Higher Levels of SERCA2b, but Not of SERCA3
Protein--
Western blots of PC12 cell lysates stained with the
SERCA2b-specific antibody (35) showed one band at 115 kDa in accordance with the known size of SERCA2b (Fig.
7A, upper part). In
PC12 cell lysates, proteins with molecular mass of 105 and 116 kDa were
stained with an antibody directed against an N-terminal epitope shared
by, and specific for, all SERCA3 isoforms (36) (Fig. 7A,
lower part). The 105-kDa immunoreactive protein exhibited a
tissue distribution profile in agreement with that described for SERCA3
mRNA (Ref. 15 and results not shown), most likely reflecting the
presence of SERCA3a (999 amino acids) isozyme. The size of the 116-kDa
band suggests that it corresponds to the novel SERCA3b/c (1067 amino
acids), recently identified (17). Fig. 7 (A and
C) shows that the SERCA2b immunostaining increased after
exposure to thapsigargin, A23187, EGTA, tunicamycin, and DTT for 8 h, whereas SERCA3 staining intensity remained at a steady level. Longer
stress treatments (16 h) did not enhance the level of SERCA2b further.
No effect was found of BFA or Azc on the SERCA2b level at 8 h
(Fig. 7C).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 7.
SERCA2b immunoreactive protein and SERCA
phosphorylated intermediate are up-regulated by ER stressors.
A, Western blots imunostained with SERCA2b-specific
(upper part) and SERCA3-specific (lower part)
antibodies. PC12 cells were treated with the ER stress-inducing agents
(concentrations as in Fig. 1A) for 8 or 16 h, as
indicated. Total cell lysates were analyzed, 15 µg/lane for SERCA2b
(five experiments) and 50 µg/lane for SERCA3 (two experiments).
Positions of molecular mass markers are indicated (in kDa).
B, measurement of Ca2+-ATPase phosphorylated
intermediate. PC12 cells were treated for 7 h with the indicated
agents, the microsomes were isolated, and the phosphorylation carried
out using [ -32P]ATP at 0 °C for 20 s, followed
by TCA precipitation, and analysis on acidic SDS-PAGE. The indicated
band with an apparent molecular mass of 105 kDa represents SERCA2b and
SERCA3 proteins, not separated because of a lower resolution of this
acidic SDS-PAGE gel. C, quantitation of the immunoreactive
SERCA2b protein (after 8 h of stress exposure) and of SERCA E~P
(7 h of stress). The optical density of the bands was measured and
expressed relative to untreated controls (means ± S.D.;
n = 5 for Tun, DTT, Tg, A23187, and EGTA;
n = 3 for BFA; n = 2 for Azc).
Statistical significance of differences were relative to control
p < 0.05 (*) and p < 0.01 (**) as
measured by Student's t test. DMSO, dimethyl
sulfoxide.
|
|
Total Active SERCA Is Up-regulated after 7 h of
Stress--
An impaired folding and processing of proteins is at the
heart of the ER stress, with an obvious potential for an impairment of
function. To test whether the stress-induced increase in the synthesis
of SERCA2b resulted in a functional protein, we measured the level of
the phosphorylated Ca2+-ATPase intermediate in microsomes
from PC12 cells. We have previously shown that the single radioactive
band obtained in this phosphorylation assay represents a sum of SERCA2b
and SERCA3 E~Ps (Ref. 39 and results not shown). Fig. 7 (B
and C) shows that treatment of PC12 cells with A23187, EGTA,
or DTT for 7 h did produce an increase in the amount of the
phosphorylatable enzyme intermediate.
Protein and DNA Synthesis Are Differentially Inhibited by ER
Stressors in PC12 Cells--
The ER stress response has been shown to
be accompanied by an inhibition of translation because of the
activation of PKR-like ER kinase and/or PKR protein kinases (30, 31).
DNA synthesis and cell cycle progression were also found to be
perturbed in stressed cells through an inhibition of cyclin D1 mRNA
translation (50). To see whether the increased synthesis of SERCA2b
protein during the ER stress occurred against a background of a
decrease in the global protein and DNA synthesis, we tested whether
these processes were perturbed in stressed PC12 cells. From Fig.
8 it appears that the inhibition of
protein synthesis was very dependent on the particular type of
stressor. Treatment with A23187 and thapsigargin resulted in only
little or no reduction in the global protein synthesis rate. Treatments
with DTT, tunicamycin, EGTA, or Azc resulted in an intermediate
inhibition of protein synthesis to about 50-70%, whereas BFA
inhibited protein synthesis to about 30% of the control. In contrast,
the rate of DNA synthesis was depressed by all ER stressors, decreasing
to about 20-40% of the controls.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 8.
Protein and DNA synthesis rates in PC12 cells
during ER stress. PC12 cells were treated by ER stress-producing
agents (as in Fig. 1) or cycloheximide (CHX) for a period of
8 h. DNA and protein synthesis rates were determined, normalized
to cell numbers for each condition (differing less than 20%), and
expressed as percentages of the rates measured in vehicle-treated cells
(dimethyl sulfoxide or H2O). For each treatment, cell
survival was >93% based on trypan blue exclusion. Shown are the
means ± S.D. (n = 3). DMSO, dimethyl
sulfoxide.
|
|
Depletion of ER Calcium Is Not an Obligatory Step for Activation of
UPR or Up-regulation of SERCA2b by ER Stress--
Although depletion
of Ca2+ from the ER by thapsigargin, A23187, or EGTA is
known to activate UPR (8), it has not been established whether
initiation of the UPR response is always associated with such
depletion. Resolution of this issue was of interest for at least two
reasons. First, if induction of UPR were invariably accompanied by ER
Ca2+ loss, one might suspect that such loss was
obligatorily linked to the UPR activation. Second, independently of the
precise relationship between UPR initiation and ER Ca2+
loss, such loss might be expected to be the key factor controlling the
up-regulation of SERCA2b, in view of the obvious homeostatic rationale
for such a mechanism. We therefore carried out experiments to estimate
the size of the lumenal ER Ca2+ pool following treatment
with various stress-inducing agents, emphasizing those agents whose
ability to interfere with ER Ca2+ homeostasis has not been
generally established, i.e. DTT, tunicamycin, BFA, and Azc.
In these experiments (Fig. 9), the cells
were exposed to the stressor, followed by a removal of extracellular
Ca2+ and an application of a test stimulus (a
Ca2+-mobilizing agonist or thapsigargin) to release the ER
Ca2+. PC12 cells in a resting state had a cytosolic
Ca2+ concentration ([Ca2+]i) between
40 and 50 nM. They responded to stimulation with
acetylcholine with a transient increase in [Ca2+
]i (Fig. 9A, panel a), demonstrating the
operation of a functional Ca2+ signaling system.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 9.
The stressed ER is not calcium-depleted.
Single cell free cytosolic Ca2+
[Ca2+]i measurements were carried out with fura-2
ratio technique. The ordinate indicates nM
[Ca2+]i, and the abscissa indicates
time in seconds. Means of recordings from 20-40 cells in each
microscopic field are shown. A, panels a and
b, validation of the assay system. PC12 cells show transient
raise in [Ca2+ ]i upon stimulation with
acetylcholine (panel a, ACh, arrow),
or upon SERCA blockade by Tg (panels a and b, 300 nM, open arrowhead). Panels c-e,
short term exposure to ER stressors does not release ER
Ca2+. Agents (panel c, Me2SO 0.1%
v/v), Tun (panel d, 10 µg/ml) or Azc (panel e,
5 mM) were added at 180 s (long arrow).
After 18-20 min, PC12 cells were washed with Ca2+-free EM
solution supplemented with 25 µM EGTA (filled
arrowhead), and thapsigargin was added (open arrowhead,
300 nM), followed by ionomycin (diamond, 2 µM). Values are representative of three independent
experiments. B, long term exposure to ER stressors does not
release ER Ca2+. Cells were treated for 4 h with the
indicated stressors, loaded with fura-2, and subjected to calcium
imaging. At 180 s (filled arrowhead) extracellular
Ca2+ was removed by three washes in nominally
Ca2+-free EM solution. At 360 s cells were stimulated
by 100 µM acetylcholine (arrow). At 600 s
300 nM thapsigargin was added (open arrowhead).
Values are representative of three independent experiments.
|
|
Treatment with thapsigargin (Fig. 9, A, panel b,
and B, panel b, Tg addition at
4 h) elicited a long
lasting elevation of [Ca2+]i as expected from the
activation of store-operated Ca2+ channels in the plasma
membrane (51). Fig. 9A (panels d and e) shows that no perturbation of [Ca2+
]i within 18-20 min from addition of tunicamycin or Azc was
observed, and addition of thapsigargin followed by ionomycin in
Ca2+-free medium produced increases in the cytosolic free
Ca2+ not different from those observed in control cells
(Fig. 9A, panel c). The use of DTT as stressor
gave analogous results. Therefore, tunicamycin, Azc, or DTT did not act
as immediate or direct releasers of ER Ca2+. To test
whether any such Ca2+ releasing action of these compounds
would occur in the time frame necessary for ER stress induction, cells
were treated with these compounds for 4 h. Fig. 9B
shows that 4-h exposures to tunicamycin (panel c), DTT
(panel d), or Azc (panel e) did not result in a significant depletion of Ca2+ from ER. Resting
[Ca2+ ]i, before removal of extracellular
Ca2+, was at a level equal to that in the control
(Me2SO-exposed) cells or slightly lower, indicating that
store-operated Ca2+ channels were not activated, as would
have been the case had the ER Ca2+ been depleted and as
seen in Fig. 9 (A, panels a and b, and
B, panel b). Importantly, in comparison with
controls, thapsigargin was able to release similar amounts of
Ca2+ (corresponding to a rise in
[Ca2+]i of about 20 nM) in Azc-,
tunicamycin-, or DTT-treated cells. In contrast, Fig. 9B
(panel b) shows that an equivalent 4-h exposure to
thapsigargin as a stressor abolished a subsequent effect of this drug
applied as a test stimulus. Panel b also shows that
thapsigargin-mediated emptying of ER Ca2+ store resulted in
the expected capacitative Ca2+ entry, evidenced by an
elevated [Ca2+]i (~75 nM, a value
before introduction of Ca2+-free medium), when compared
with control cells as well as to cells exposed to Azc, tunicamycin, or
DTT (~40-45 nM, before introduction of
Ca2+-free medium). The response to acetylcholine appeared
somewhat smaller following these treatments in some experiments. It
should be noted that the results with BFA (Fig. 9B,
panel f) present a special case; although there was a
clearly elevated [Ca2+]i level, the ER
Ca2+ store was not depleted, as evidenced by a large
increase of [Ca2+]i upon application of
thapsigargin test stimulus (Fig. 9B, panel f,
open arrowhead). (The reasons for this BFA-mediated elevation of [Ca2+]i were not investigated.)
 |
DISCUSSION |
The parameters that need to be set correctly and coordinated for
the ER-lumenal protein processing to proceed successfully include the
total available capacity of the chaperones and folding enzymes and the
physico-chemical parameters within the ER lumen, such as the oxidative
milieu, oligosaccharide availability, and the high Ca2+
concentration. A number of agents and conditions may interfere with
these parameters to evoke the ER stress response (8).
The main findings of this study focus on the regulation of ER
Ca2+-ATPase expression under conditions evoking the ER
stress response pathway known as UPR. We found a 3-4-fold selective
up-regulation of the SERCA2b mRNA level in response to an array of
UPR inducing agents. In contrast, there was no change in the SERCA3
mRNA level (Fig. 1). An earlier study has suggested that the
intra-ER Ca2+ content may be an important determinant of
SERCA expression, because depletion of ER Ca2+ resulted in
an increased production of SERCA mRNA (however, no distinction was
made between SERCA2 and SERCA3 mRNAs) (52). Our present findings
agree with these earlier results. However, the present study
substantially enlarges the context of SERCA expression regulation to
that of the ER stress response in general, because of the inclusion of
several stress conditions not expected a priori to affect
the ER Ca2+ content. We confirmed such lack of any
significant ER Ca2+ perturbation upon either short term or
longer exposure of PC12 cells to DTT, tunicamycin, or Azc, by direct
measurements of the thapsigargin-releasable ER Ca2+ (Fig.
9). Therefore, we propose that the induction of SERCA2b mRNA was
linked to the activation of the UPR by the stressed ER rather than
representing an adjustment to the depletion of the ER Ca2+.
More generally, these results also indicate that although the Ca2+-releasing agents have been employed in studies of the
UPR (8), ER Ca2+ depletion is not a necessary requirement
to trigger this pathway.
Several independent lines of evidence support the up-regulation of
SERCA2b mRNA as reflecting the activation of the UPR pathway. First, several features of the SERCA2b mRNA up-regulation
corresponded closely to those observed for the mRNA of BiP, the
well studied UPR-induced ER chaperone measured in parallel in our
system. Thus, the increase in SERCA2b mRNA occurred at a time scale
similar to that for BiP (2-4 h), was similarly reversible upon the
removal of the stress agent, and could be reinduced upon the
reintroduction of this agent. Second, it is well established that the
ER stress-induced increase of BiP mRNA requires protein synthesis
(46) and is due to a transcriptional activation (53). We have shown
that these characteristics did apply to the increase in the amount of
the SERCA2b mRNA, based on the inhibition of the response by cycloheximide and actinomycin D and the lack of mRNA stabilization. Third, an analysis of the promoter region of SERCA2 genes revealed, within the first 1000 nucleotides upstream to the transcription initiation site, up to three copies of the nucleotide sequences showing
at least 80% identity with the recently identified ERSE consensus
sequence (Fig. 10A). ERSE
regulatory elements have recently been shown to be sufficient and
necessary for the induction of the ER stress genes in higher eukaryotes
(27, 28). The ERSE consensus sequence encompasses 19 base pairs and has
an overall structure CCAAT(N9)CCACG (Fig. 10A),
proposed on the basis of promoter comparison between ER
stress-regulated genes as well as functional studies (27, 28). It may
be seen in Fig. 10A that the SERCA2 ERSE1 was conserved
between species and agreed with the consensus ERSE, except for the
substitution of adenine for guanine in position 19. ERSE position 19 is
also substituted to adenine in the ERSE-like element of GRP58 (54)
(Fig. 10A) and is the least conserved position in the ERSE
consensus sequence. Several ERSE2 and ERSE3 sequences of SERCA2 genes
showed additional divergences from the ERSE consensus. Importantly,
SERCA2 ERSE1 from all species analyzed contained the GGC motif within
the nine intervening nucleotides. On the other hand, this GGC motif was
missing in the single ERSE-like element identifiable within the SERCA3
gene, presumably invalidating the SERCA3 ERSE, because the functional
importance of this nucleotide triplet has been demonstrated by
mutagenesis of the rat the BiP promoter (28). Similarly, the presence
of only a single ERSE-like element in SERCA3 gene, in contrast to the
multiple copies in SERCA2, may also constitute a functionally important
difference (27, 28). Yeast ER stress gene promoters contain the
unfolded protein response element (UPRE, defined by the core sequence
GACAGCGTGTC), which mediates ER stress gene up-regulation through
binding of the transcription factor Hac1 (55). Recently, binding of
yeast Hac1 to an UPRE-like sequence (GCCAGCTTG) in the rat BiP promoter was reported, indicating that a putative mammalian Hac1 homolog might
enhance the mammalian ER stress response (56). The SERCA2 promoter
contains an UPRE-like sequence resembling the yeast BiP UPRE and rat
BiP UPRE (Fig. 10B). Thus, SERCA2 promoters contain conserved sequences (ERSE and UPRE) known to mediate up-regulation of
ER stress proteins.

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 10.
SERCA2 gene promoter contains ERSE-like and
UPRE-like elements. A, ERSEs found in SERCA2 and SERCA3
genes, as well as in BiP and GRP58 genes, are aligned. The 19 base
positions are indicated 5' 3'. For the ERSE consensus (top
row), the 5'-terminal and 3'-terminal base quintets are shown on a
light gray background, whereas the GGC triplets are on a
dark gray background. For the individual genes, the
light gray background indicates nucleotides identical to
those within the consensus ERSE flanking base quintets, and dark
gray indicates nucleotides identical to the consensus middle
segment GGC motifs (28). For each ERSE, the distance in base count of
the first C from the initiation of transcription (set to +1) is
indicated by a negative number. For each gene, up to three ERSEs found
are numbered 1-3 in the order of increasing distance upstream from the
transcription initiation site. (L) indicates that the
element is found on the noncoding lower strand. B, alignment
of UPRE-like sequences of SERCA2 and SERCA3 genes with those of yeast
and rat BiP. Nucleotides shown on light or dark gray
backgrounds are important for yeast BiP induction (55).
Nucleotides on a dark gray background were found important
for the binding of yeast UPR-activating factor Hac1p to rat BiP UPRE
(56). Negative numbers indicate positions relative to
transcription start, as for ERSE elements in A.
GenBankTM accession numbers: human, SERCA2, AC006088.1;
murine, AF029982.1; rabbit, M33834.1; rat, AF031937; yeast BiP,
S40310.1; rat BiP M14866.1; SERCA3, Y15724.
|
|
The present work also demonstrates a selective up-regulation of SERCA2b
(but not SERCA3) immunoreactive protein under the conditions of ER
stress (Fig. 7). Unlike the relatively uniform effect of all the tested
agents on the level of SERCA2b mRNA (3-4-fold increase), the
resulting protein level varied from a 2.5-fold increase with
thapsigargin or A23187, to no increase at all with BFA or Azc. Notably,
a general correlation appeared to exist between the relative strength
of the effect of each agent on SERCA2b immunoreactive protein and its
effect on the global rate of protein synthesis (Figs. 7 and 8). These
data suggest that the SERCA2b protein synthesis was reflecting the
overall state of protein synthesis in the cell. This is at a variance
from BiP, whose preferential synthesis even in the face of a strong
translation inhibition is enabled by a unique, 5'-cap-independent
mechanism of ribosomal loading for BiP mRNA (31).
The formation of the E~P upon incubation with [32P]ATP
was used to quantitate SERCA pumps in an activity-dependent
manner (39). As seen in Fig. 7C, the four tested ER
stress-inducing agents did cause a statistically significant increase
in SERCA E~P, albeit by a factor smaller than the corresponding
increase in the immunoreactive SERCA2b. This discrepancy was at least
in part due to the fact that the acid SDS-PAGE system used for the
E~P analysis (as distinct from the SDS-PAGE according to Laemmli
(34)) was unable to resolve SERCA2b and SERCA3 E~Ps. Hence, the
stress-unresponsive SERCA3 contribution to the E~P band at 105 kDa
(Fig. 7C) must have partly obscured the stress-induced
response because of SERCA2b. In addition, the level of SERCA E~P was
measured in microsomes, in contrast to whole cell extracts used to
measure SERCA2b immunostaining.
In summary, the experimental data (Figs. 1-6), as well as the analysis
of the SERCA2 gene promoters (Fig. 10) strongly suggest that SERCA2
transcription is selectively activated by the UPR pathway, along with
other ER stress-inducible genes and that this gives rise to an elevated
level of active SERCA2b protein in the cell following ER stress (Fig.
7).
Given the universal nature of UPR, the observation of the specific
association of SERCA2b, rather than SERCA3, with the ER stress-induced
UPR agrees well with the ubiquitous nature of SERCA2b distribution.
Indeed, SERCA2b has been regarded as a "householding" Ca2+-ATPase present in all tissues except cardiac and
skeletal muscle, whereas SERCA3 displays a somewhat narrower
distribution (11, 15, 16).
From the point of view of Ca2+ homeostasis it seems
intriguing that significant up-regulation of SERCA2b should take place
with no apparent change in the ER content of Ca2+ upon ER
stress induced by agents like tunicamycin, DTT, or Azc. It may be
speculated that an enhanced Ca2+ uptake activity into the
ER might act to shorten the period of a relative ER Ca2+
depletion subsequent to a stimulus-induced ER Ca2+ release,
in this way responding to an increased demand for Ca2+ by
the ER chaperone system under conditions where unfolded proteins are accumulated.
One example of a possible pathophysiological relevance of the SERCA2b
regulation by the UPR came from the recent identification of the
presenilin-1 as a regulator of the mammalian UPR. Presenilin-1 mutations, known to underlie a large proportion of familial
Alzheimer's disease cases, down-regulate UPR (57). Interestingly, such
a presenilin-1 mutation was also shown to cause a destabilization of
cellular Ca2+ homeostasis (58). It is tempting to speculate
that this destabilization of Ca2+ homeostasis resulted from
a low SERCA2b level, because of a down-regulated UPR, in agreement with
SERCA2b expression being linked to the UPR as reported here.
 |
ACKNOWLEDGEMENT |
We thank Inge Østermark Johansen for
excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported by the Danish Government
Biotechnology Program, Gerda and Aage Haensch's Foundation, and the
Danish Medical Research Council.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Recipient of a Ph.D. studentship from the Faculty of Health
Sciences of the University of Copenhagen.
To whom correspondence should be addressed: Dept. of Medical
Physiology, Panum Inst., Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.
Tel.: 45-3532-7510; Fax: 45-3532-7537; E-mail:
M.Treiman@mfi.ku.dk.
Published, JBC Papers in Press, March 29, 2000, DOI 10.1074/jbc.M001569200
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic
reticulum;
SERCA, sarco/endoplasmic reticulum calcium-ATPase;
UPR, unfolded protein response;
Azc, L-azetidine 2-carboxylic
acid;
BFA, brefeldin A;
Tun, tunicamycin;
Tg, thapsigargin;
GRP, glucose-regulated protein;
BiP, immunoglobulin-binding protein;
PKR, RNA-dependent protein kinase;
CHOP, C/EBP homology protein;
ERSE, ER stress elements;
UPRE, UPR elements;
E~P, phosphorylated
intermediate of SERCA;
DTT, dithiothreitol;
kb, kilobase(s);
Tes, 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic
acid;
PAGE, polyacrylamide gel electrophoresis;
PBS, phosphate-buffered
saline;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
 |
REFERENCES |
| 1.
|
Berridge, M. J.
(1993)
Nature
361,
315-325
|
| 2.
|
Ghosh, T. K.,
Bian, J., H.,
Short, A. D.,
Rybak, S. L.,
and Gill, D. L.
(1991)
J. Biol. Chem.
266,
24690-24697
|
| 3.
|
Berridge, M. J.
(1995)
BioEssays
17,
491-500
|
| 4.
|
Lodish, H. F.,
and Kong, N.
(1990)
J. Biol. Chem.
265,
10893-10899
|
| 5.
|
Cooper, G. R.,
Brostrom, C. O.,
and Brostrom, M. A.
(1997)
Biochem. J.
325,
601-608
|
| 6.
|
Lodish, H. F.,
Kong, N.,
and Wikström, L.
(1992)
J. Biol. Chem.
267,
12753-12760
|
| 7.
|
Hammond, C.,
and Helenius, A.
(1995)
Curr. Opin. Cell Biol.
7,
523-529
|
| 8.
|
Kaufman, R. J.
(1999)
Genes Dev.
13,
1211-1233
|
| 9.
|
Corbett, E. F.,
Oikawa, K.,
Francois, P.,
Tessier, D. C.,
Kay, C.,
Bergeron, J. J. M.,
Thomas, D. Y.,
Krause, K.-H.,
and Michalak, M.
(1999)
J. Biol. Chem.
274,
6203-6211
|
| 10.
|
Meldolesi, J.,
and Pozan, T.
(1998)
Trends Biochem. Sci.
23,
10-14
|
| 11.
|
Burk, S. E.,
Lytton, J.,
MacLennan, D. H.,
and Shull, G. E.
(1989)
J. Biol. Chem.
264,
18561-18568
|
| 12.
|
Brandl, C. J.,
deLeon, S.,
Martin, D. R.,
and MacLennan, D. H..
(1987)
J. Biol. Chem.
262,
3768-3774
|
| 13.
|
Gunteski-Hamblin, A.-M.,
Greeb, J.,
and Shull, G.
(1988)
J. Biol. Chem.
263,
15032-15040
|
| 14.
|
Lytton, J.,
and MacLennan, D. H.
(1988)
J. Biol. Chem.
263,
15024-15031
|
| 15.
|
Wu, K.-D.,
Lee, W.-S.,
Wey, J.,
Bundgard, D.,
and Lytton, J.
(1995)
Am. J. Physiol.
269,
C775-C784
|
| 16.
|
Dode, L.,
De Greef, C.,
Mountian, I.,
Attard, M.,
Town, M. M.,
Casteels, R.,
and Wuytack, F.
(1998)
J. Biol. Chem.
273,
13982-13994
|
| 17.
|
Martin, V.,
Bredoux, R.,
Corvazier, E.,
Papp, B.,
and Enouf, J.
(2000)
Hypertension
35,
91-102
|
| 18.
|
Launay, S.,
Bobe, R.,
Lacabaratz-Porret, C.,
Bredoux, R.,
Kovàcs, T.,
Enouf, J.,
and Papp, B.
(1997)
J. Biol. Chem.
272,
10746-10750
|
| 19.
|
Lee, M. G.,
Xu, X.,
Zeng, W.,
Diaz, J.,
Kuo, T. H.,
Wuytack, F.,
Racymaekers, L.,
and Muallem, S.
(1997)
J. Biol. Chem.
272,
15771-15776
|
| 20.
|
Kozutsumi, Y.,
Segal, M.,
Normington, K.,
Gething, M. J.,
and Sambrook, J.
(1988)
Nature
332,
462-464
|
| 21.
|
Lee, A. S.
(1987)
Trends. Biochem. Sci.
12,
20-23
|
| 22.
|
Morris, J. A.,
Dorner, A. J.,
Edwards, C. A.,
Hendershot, L. M.,
and Kaufman, R. J.
(1997)
J. Biol. Chem.
272,
4327-4334
|
| 23.
|
Little, E.,
and Lee, A. S.
(1995)
J. Biol. Chem.
270,
9526-9634
|
| 24.
|
Chapman, R.,
Sidrauski, C.,
and Walter, P.
(1998)
Annu. Rev. Cell Dev. Biol.
14,
459-485
|
| 25.
|
Tirasophon, W.,
Welihinda, A. A.,
and Kaufman, R. J.
(1998)
Genes Dev.
12,
1812-1824
|
| 26.
|
Wang, X. Z.,
Harding, H. P.,
Zhang, Y.,
Jolicoer, E. M.,
Kuroda, M.,
and Ron, D.
(1998)
EMBO J.
17,
5708-5717
|
| 27.
|
Yoshida, H.,
Haze, K.,
Yanagi, H.,
Yura, T.,
and Mori, K.
(1998)
J. Biol. Chem.
273,
33741-33749
|
| 28.
|
Roy, B.,
and Lee, A. S.
(1999)
Nucleic Acids Res.
27,
1437-1443
|
| 29.
|
Wang, X. Z.,
Lawson, B.,
Brewer, J. W.,
Zinszner, H.,
Sanjay, A.,
Mi, L. J.,
Boorstein, R.,
Kreibich, G.,
Hendershot, L. M.,
and Ron, D.
(1996)
Mol. Cell. Biol.
16,
4273-4280
|
| 30.
|
Harding, H. P.,
Zhang, Y.,
and Ron, D.
(1999)
Nature
397,
271-274
|
| 31.
|
Brostrom, C. O.,
and Brostrom, M. A.
(1998)
Prog. Nucleic Acids Res. Mol. Biol.
58,
79-125
|
| 32.
|
Chomczynski, P.,
and Sacchi, N
(1987)
Anal. Biochem.
162,
156-159
|
| 33.
|
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K.
(eds)
(1989)
Current Protocols in Molecular Biology
, John Wiley & Sons, Inc., New York
|
| 34.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 35.
|
Wuytack,
Frank,
Eggermont, J. A.,
Raeymaekers, L.,
Plessers, L,
and Casteels, R.
(1989)
Biochem. J.
264,
765-769
|
| 36.
|
Wuytack, F.,
Papp, B.,
Verboomen, H.,
Raeymaekers, L.,
Dode, L.,
Bobe, R.,
Enouf, J.,
Bokkala, S.,
Authi, K. S.,
and Casteels, R.
(1994)
J. Biol. Chem.
269,
1410-1416
|
| 37.
|
Grynkiewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450
|
| 38.
|
Balch, W. E.,
Dunphy, W. G.,
Braell, W. A.,
and Rothman, J. E.
(1984)
Cell
39,
405-416
|
| 39.
|
Caspersen, C.,
and Treiman, M.
(1995)
FEBS Lett.
377,
31-36
|
| 40.
|
Treiman, M.,
Caspersen, C.,
and Christensen, S. B.
(1998)
Trends Pharmacol. Sci.
19,
131-135
|
| 41.
|
Bers, D. M.,
and MacLeod, K. T.
(1988)
in
Calcium in Drug Actions: Handbook of Experimental Pharmacology
(Baker, P. F., ed), Vol. 83
, pp. 491-507, Springer-Verlag, Berlin Heidelberg
|
| 42.
|
Helenius, A.
(1994)
Mol. Biol. Cell
5,
253-265
|
| 43.
|
Braakman, I.,
Helenius, J.,
and Helenius, A.
(1992)
EMBO J.
11,
1717-1722
|
| 44.
|
Li, W. W.,
Hsiung, Y.,
Zhou, Y.,
Roy, B.,
and Lee, A. S.
(1997)
Mol. Cell. Biol.
17,
54-60
|
| 45.
|
Sciaky, N.,
Presley, J.,
Smith, C.,
Zaal, K. J. M.,
Cole, N.,
Moreira, J. E.,
Terasaki, M.,
Siggia, E.,
and Lippincott-Schwartz, J.
(1997)
J. Cell Biol.
139,
1137-1155
|
| 46.
|
Resendez, E.,
Ting, J.,
Kim, K. S.,
Wooden, S. K.,
and Lee, A. S.
(1986)
J. Cell Biol.
103,
2145-2152
|
| 47.
|
Wadkins, R. M.,
and Jovin, T. M.
(1991)
Biochemistry
30,
9469-9478
|
| 48.
|
Váradi, A.,
Molnar, E.,
Östenson, C.,
and Ashcroft, S.
(1996)
Biochem. J.
319,
521-527
|
| 49.
|
Welch, W. J.
(1992)
Physiol. Rev.
72,
1063-1081
|
| 50.
|
Brewer, J. W.,
Hendershot, L. M,
Sherr, C. J.,
and Diehl, J. A.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
8505-8510
|
| 51.
|
Berridge, M. J.
(1995)
Biochem. J.
312,
1-11
|
| 52.
|
Kuo, T. H.,
Liu, B. F., Yu, Y.,
Wuytack, F.,
Raeymaekers, L.,
and Tsang, W.
(1997)
Cell Calcium
21,
399-408
|
| 53.
|
Lee, A. S.,
Delegeane, A. M.,
Baker, V.,
and Chow, P. C.
(1983)
J. Biol. Chem.
258,
597-603
|
| 54.
|
Koivunen, P.,
Horelli-Kuitunen, N.,
Helaakoski, T.,
Karvonen, P.,
Jaakkola, M.,
Palotie, A.,
and Kivirikko, K. I.
(1997)
Genomics
42,
397-404
|
| 55.
|
Mori, K.,
Ogawa, N.,
Kawahara, T.,
Yanagi, H.,
and Yura, T.
(1998)
J. Biol. Chem.
273,
9912-9920
|
| 56.
|
Foti, D. M.,
Welihinda, A.,
Kaufman, R. J.,
and Lee, A. S.
(1999)
J. Biol. Chem.
274,
30402-30409
|
| 57.
|
Katayama, T.,
Imaizumi, K.,
Sato, N.,
Miyoshi, K.,
Kudo, T.,
Hitomi, J.,
Mojihara, T.,
Yoneda, T.,
Gomi, F.,
Mori, Y.,
Nakano, Y.,
Takeda, J.,
Tsuda, T.,
Itoyama, Y.,
Murayama, O.,
Takashima, A.,
George-Hyslop, P. S.,
Takeda, M.,
and Tohiyama, M.
(1999)
Nat. Cell Biol.
1,
479-485
|
| 58.
|
Mattson, M. P.,
Zhu, H., Yu, J.,
and Kindy, M. S.
(2000)
J. Neurosci.
20,
1358-1364
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike